bodybuilding semaglutide The GLP-1 Muscle Loss Scare: Why the Research Is Widely Misunderstood Separating Fact from Fiction: Demystifying

Its dual GIP/GLP-1 function produces substantially greater results than the GLP-1-only approach of Rybelsus

If underlying eating patterns and metabolic drivers have not been addressed, weight regain is common

Pilon-Thomas et al

Nat Commun 15 , 9405 (2024)

carnitine deficiency will recur quickly without consistent replacement

Across the full GLP-1 and obesity drug space, the post-2026 picture is a price-expansion wave led by Indian and Chinese biosimilars and by new dual or triple-agonist molecules, yet real uptake in the USA and EU will be shaped less by tariffs and more by regulatory timing, drug-device parity on pens and human-factors equivalence for AB-substitution, secondary IP and Orange Book hurdles, and payer or formulary contracting